Genito Urinary System And Sex Hormones

Vera concludes Phase IIb IgA nephropathy trial subject enrolment

Vera Therapeutics has concluded subject enrolment in the Phase IIb ORIGIN clinical trial of atacicept in IgA nephropathy (IgAN) patients.…

Urovant reports positive data from Phase IIa OAB therapy trial

Urovant Sciences has reported positive topline data from the Phase IIa clinical trial of its investigational gene therapy product, URO-902,…

Major unmet needs in overactive bladder unlikely to be addressed in the near future

Unmet needs within the overactive bladder (OAB) market are significant and largely expected to persist throughout the next decade, according…

Regulatory roundup: Editas’ CRISPR asset make strides after positive eye disease trial

Need to know: GlobalData’s Investigative News team reviews data generated by an in-house model that combines machine learning and its…

Semaine: building an evidence base in women’s health

After years of witnessing his wife Lauren Lee-Crane and her twin sister Catherine Lee suffering at the hands of endometriosis…

Poor adherence to overactive bladder medication signifies need for novel drugs

On 8 June, the university medical centres Maastricht UMC+ and Erasmus MC announced that they have been awarded a grant…

September’s top news stories

NIH kick starts hunt for neuroprotective stroke treatments The US National Institute of Health (NIH) launched a search for neuroprotective…